Compare DRH & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRH | ATEC |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | N/A | 2006 |
| Metric | DRH | ATEC |
|---|---|---|
| Price | $9.21 | $12.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $9.84 | ★ $22.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $2.99 | $18.97 |
| Revenue Next Year | $1.99 | $16.26 |
| P/E Ratio | $38.41 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.19 | $8.82 |
| 52 Week High | $10.67 | $23.29 |
| Indicator | DRH | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 38.34 | 39.16 |
| Support Level | $9.05 | $12.03 |
| Resistance Level | $9.37 | $12.97 |
| Average True Range (ATR) | 0.26 | 0.52 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 0.58 | 28.63 |
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.